Pneumococcal carriage study for kids and older adults
Part of Infections clinical trials.
This study checks how common pneumococcal bacteria are in the nose and throat of healthy children and adults after the pandemic. It involves one online questionnaire and one gentle nasal swab.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child aged 7 months to 5 years, or an adult 50 or older.
- You can read and speak English.
- You have not taken antibiotics in the last 2 weeks.
- You do not have a current respiratory infection like a cold or flu.
- You do not have a chronic condition that affects your immune system or breathing (for example, immune deficiency, cystic fibrosis, or cerebral palsy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long the bacteria that can cause pneumonia and ear infections stay in a child's nose and throat. It may help researchers understand how these germs spread and how to prevent infections in the future.
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
This study collects nasal swabs from young children in Malaysia to learn which types of pneumococcal bacteria are present, which antibiotics work against them, and how they spread. This information helps doctors better treat and prevent pneumococcal infections in children.
This study looks at bacteria (especially pneumococcus) in the nose and throat of children. It includes children with ear infections or healthy children, to understand which germs are carried and how they relate to illness.
This research study examines how a common bacterium called pneumococcus lives in the noses of young children who are hospitalized with respiratory symptoms. The goal is to understand which types of pneumococcus are present in Vietnam to help improve prevention and treatment strategies.
This trial tests a catch-up pneumococcal vaccine for children and adolescents who may have missed some doses. It aims to see how safe and effective the vaccine is in healthy kids aged 15 months to 17 years.
Hear when a new Pneumococcal Carriage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.